ArticlePloS one2025
Female genital mutilation and its effects among women of reproductive age in Kenya: Insights from Kenya Demographic and Health Survey 2022.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionFemale genital mutilation (FGM) is a significant public health issue rooted in cultural traditions, affecting millions of women and girls. In Kenya, the practice is prevalent in various ethnic groups and is often associated with social and economic pressures.
objectiveTo determine the prevalence of FGM, the factors associated with FGM, and its effects among women of reproductive age in Kenya.
methodsThis study used secondary data of a total 16,716 weighted women of reproductive age drawn from the 2022 Kenya Demographic and Health Survey. The study used the "svy" command in Stata to assign the sample weight. Multivariable logistic regression was used to assess significant factors associated FGM and statistical significance was set at a 5% significance level.
resultsThe overall prevalence of FGM among women of reproductive age in Kenya was 14.8% (95% CI = 13.98, 15.67). The findings showed that the following factors were associated with FGM: age 30-39 years (aOR=1.66, 95% CI = 1.28, 2.16) and age 40-49 years (aOR=2.71, 95% CI = 2.06, 3.57), residing in rural areas (aOR=1.37, 95% CI = 1.11, 1.68), no education (aOR=3.45, 95% CI = 2.69, 4.41) or primary education (aOR=1.40, 95% CI = 1.20, 1.64), being poor (aOR=1.76, 95% CI = 1.38, 2.25) or middle-income (aOR=1.34, 95% CI = 1.08, 1.66), being married (aOR=1.71, 95% CI = 1.37, 2.13) or separated (aOR=1.56, 95% CI = 1.17, 2.07), believing that FGM is required by religion (aOR=2.03, 95% CI = 1.37, 2.99), culture (aOR=4.79, 95% CI = 3.80-6.05), and society (aOR=2.65, 95% CI = 1.96, 3.58), FGM continued to be practiced (aOR=2.76, 95% CI = 2.14, 3.55), having a male household head (aOR=1.19, 95% CI = 1.02, 1.38), and never listening to the radio (aOR=1.31, 95% CI = 1.11, 1.54). Additionally, the results indicated that the most common side effects were severe pain (70.3%) and heavy bleeding (45.9%).
conclusionFGM is still a prevalent practice in Kenya despite being outlawed. gender and social norms contribute to the sustenance of the practice. The emerging trends including medicalization and change in the age of cutting need to be addressed. The factors that accelerate and enhance the practice of FGM need to be addressed and advocate more against the practice of FGM as it is a violation of human rights.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.